In patients with active ulcerative colitis treated with leukocytapheresis, LL‑37 concentration increased within the apheresis system lines.
In plain wordsIn people with ulcerative colitis having blood-cell filtering, the body's own LL‑37 levels rose inside the filtering system lines.
- Peptide
- LL-37
- Outcome
- IncreaseLL-37 concentration within apheresis system lines
- Study
n: not reported in source
- Outcome group
- Immune response · Immune and inflammation
Source sentences
Concentration of LL-37 increased within the apheresis system lines.
1 context sentence(design, population, supporting numbers)
We evaluated safety and efficacy of the modified Cellsorba using ACD-A in a pilot trial comprising patients with active UC, despite receiving 5-ASA.
This result measures the body's own LL-37. Nobody was given the peptide. It is not evidence about taking it.